foxo4-dri senolytic 2024 study

foxo4-dri senolytic 2024 study FOXO4 -DRI (10MG)INJECTION, Packaging Type: Vial at ₹ 3200/piece in Nagpur Development of a novel senolytic

Name: foxo4-dri senolytic 2024 study FOXO4 -DRI (10MG)INJECTION, Packaging Type: Vial at ₹ 3200/piece in Nagpur Development of a novel senolytic
Brand: usmivani.cz
SKU: 6801751665
Price: 25.43 USD
Availability: InStock
Rating: 4.5265 (23 reviews)

Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications

SKU: 6801751665 · From usmivani.cz

4.5

USD25.43 USD52.43

Pay in 4 interest-free payments of $6.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Circulation 100 : 11611168

Andersson, Emmanuel Shapira, Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC), The Journal of Pediatrics, Volume 132, Issue 1, January 1998, Pages 121-124, ISSN 0022-3476, Okuda K, Yashima K, Kitazaki T, Takara I